# Whole Body Diffusion MRI for Non-invasive Lesion Detection and Therapy Follow-up: Study With Patients With Ovarian Cancer and Peritoneal Metastasis

> **NCT01242436** · NA · COMPLETED · sponsor: **Universitaire Ziekenhuizen KU Leuven** · enrollment: 50 (actual)

## Conditions studied

- Ovarian Cancer
- Peritoneal Metastasis

## Interventions

- **PROCEDURE:** intravenous contrast administration

## Key facts

- **NCT ID:** NCT01242436
- **Lead sponsor:** Universitaire Ziekenhuizen KU Leuven
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2013-12
- **Final completion:** 2014-12
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2015-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01242436

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01242436, "Whole Body Diffusion MRI for Non-invasive Lesion Detection and Therapy Follow-up: Study With Patients With Ovarian Cancer and Peritoneal Metastasis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01242436. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*